Results 171 to 180 of about 5,171 (262)

Emergent open distal pancreatosplenectomy-symptomatic giant splenic artery aneurysm: a case report. [PDF]

open access: yesJ Surg Case Rep
Steinkraus KC   +5 more
europepmc   +1 more source

EAES Clinical Practice Guideline 2026 Protocol: Multi‐Society Recommendations for the Treatment of Achalasia

open access: yesClinical and Public Health Guidelines, Volume 3, Issue 2, April 2026.
ABSTRACT Introduction Achalasia causes significant distress and quality‐of‐life impairment to patients. Several options exist for the treatment of achalasia including endoscopic [intra‐sphincteric injection of botulinum toxin, pneumatic dilation, peroral endoscopic myotomy (POEM)], and surgical techniques such as Heller Myotomy.
Bright Huo   +7 more
wiley   +1 more source

Local ice cryotherapy reduced vascular inflammation in large artery from rats with arthritis. [PDF]

open access: yesSci Rep
Peyronnel C   +8 more
europepmc   +1 more source

Thrombopoietin Receptor Agonists Plus Immunosuppressive Therapy in Aplastic Anaemia: A Systematic Review and Meta‐Analysis

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Background Immunosuppressive therapy (IST) is standard first‐line treatment for severe aplastic anaemia (AA) in patients ineligible for allogeneic transplantation. Thrombopoietin receptor agonists (TPO‐RAs) are increasingly added to IST to improve haematologic recovery, but long‐term safety remains uncertain.
Elham Ashrafi   +5 more
wiley   +1 more source

Successful Treatment of Aplastic Anemia With Eltrombopag During Pregnancy: A Short Report

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Introduction Aplastic anemia (AA) is a rare bone marrow failure syndrome with pancytopenia, mainly due to immune‐mediated stem cell destruction. First‐line therapy for acquired severe AA ≥ 50 years/non‐severe AA (NSAA) requiring treatment is immunosuppressive therapy with horse anti‐thymocyte globulin, cyclosporine A (CSA), and eltrombopag ...
Sandra M. Frey   +3 more
wiley   +1 more source

An improved phylogeny and revised taxonomy of Catillariaceae (Lecanoromycetes, Ascomycota)

open access: yesTAXON, Volume 75, Issue 2, April 2026.
Abstract The boundaries of the family Catillariaceae have largely remained untested through phylogenetic methods. Recent studies have led to the transfer of several genera previously classified in Catillariaceae to the newly described family Leprocaulaceae. Despite these changes, the distinction between Catillariaceae, Leprocaulaceae, and Catinariaceae
Måns Svensson   +2 more
wiley   +1 more source

Certolizumab Pegol Reduced Anterior Uveitis Flares Compared With Standard Non‐Biologic Treatment: Results From an Overlap Weighting Analysis in High‐Risk Patients With Axial Spondyloarthritis

open access: yesInternational Journal of Rheumatic Diseases, Volume 29, Issue 4, April 2026.
ABSTRACT Objective Acute anterior uveitis (AAU) is the most common extra‐musculoskeletal manifestation of axial spondyloarthritis (axSpA). This study compared the effect of the tumor necrosis factor inhibitor (TNFi) certolizumab pegol (CZP) with standard non‐biologic care, on AAU flare rate in patients with axSpA and high risk of recurrent uveitis ...
Nigil Haroon   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy